XML 42 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Stock-Based Compensation  
Schedule of stock option activity and related information

    

Number of Shares

    

Weighted - Average Exercise Price

    

Weighted-Average Remaining Contractual Term (in years)

    

Aggregate Intrinsic Value
(in thousands)

Outstanding - December 31, 2024

8,706,197

$

13.21

$

2,104

Granted

108,000

$

7.28

Exercised

(28,475)

$

3.48

$

136

Forfeited or cancelled

(115,153)

$

13.94

Outstanding - March 31, 2025

8,670,569

$

13.16

8.53

$

1,877

Options vested and exercisable as of March 31, 2025

1,434,494

$

7.93

5.62

$

1,708

Options vested and expected to vest as of March 31, 2025

8,670,569

$

13.16

8.53

$

1,877

Schedule of stock-based compensation expense as reflected in consolidated statements of operations

The Company recognized stock-based compensation expense related to the issuance of equity awards to employees and directors in the condensed consolidated statement of operations as follows (in thousands):

Three Months Ended March 31,

2025

2024

Research and development

$

1,581

$

411

General and administrative

3,805

536

Total stock-based compensation expense

$

5,386

$

947